Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor receptor 2b (FGFR2b) is a specific splice isoform of the FGFR2 gene, encoding a transmembrane receptor tyrosine kinase. FGFR2b plays critical roles in embryonic development, tissue repair, and is implicated in various cancers due to its involvement in cell proliferation, differentiation, and angiogenesis. It acts as a high-affinity receptor for FGF7 and FGF10, triggering downstream signaling cascades upon ligand binding. Overexpression or amplification of FGFR2b is observed in cancers, making it a therapeutic target.
Inhibition of FGFR2b tyrosine kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor receptor 2 (isoform b) (FGFR2b).